IVBXF
Price
$11.88
Change
-$0.00 (-0.00%)
Updated
Nov 17 closing price
Capitalization
19.71B
Intraday BUY SELL Signals
WXXWY
Price
$8.24
Change
+$0.04 (+0.49%)
Updated
Nov 18 closing price
Capitalization
16.86B
13 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

IVBXF vs WXXWY

Header iconIVBXF vs WXXWY Comparison
Open Charts IVBXF vs WXXWYBanner chart's image
Innovent Biologics
Price$11.88
Change-$0.00 (-0.00%)
Volume$15.47K
Capitalization19.71B
Wuxi Biologics (Cayman)
Price$8.24
Change+$0.04 (+0.49%)
Volume$45.53K
Capitalization16.86B
IVBXF vs WXXWY Comparison Chart in %
IVBXF
Daily Signal:
Gain/Loss:
WXXWY
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
IVBXF vs. WXXWY commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IVBXF is a Hold and WXXWY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 20, 2025
Stock price -- (IVBXF: $11.88 vs. WXXWY: $8.07)
Brand notoriety: IVBXF and WXXWY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IVBXF: 614% vs. WXXWY: 94%
Market capitalization -- IVBXF: $19.71B vs. WXXWY: $16.86B
IVBXF [@Biotechnology] is valued at $19.71B. WXXWY’s [@Biotechnology] market capitalization is $16.86B. The market cap for tickers in the [@Biotechnology] industry ranges from $106.82B to $0. The average market capitalization across the [@Biotechnology] industry is $2.15B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IVBXF’s FA Score shows that 0 FA rating(s) are green whileWXXWY’s FA Score has 1 green FA rating(s).

  • IVBXF’s FA Score: 0 green, 5 red.
  • WXXWY’s FA Score: 1 green, 4 red.
According to our system of comparison, WXXWY is a better buy in the long-term than IVBXF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IVBXF’s TA Score shows that 4 TA indicator(s) are bullish while WXXWY’s TA Score has 4 bullish TA indicator(s).

  • IVBXF’s TA Score: 4 bullish, 4 bearish.
  • WXXWY’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, IVBXF is a better buy in the short-term than WXXWY.

Price Growth

IVBXF (@Biotechnology) experienced а +8.84% price change this week, while WXXWY (@Biotechnology) price change was -5.45% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.19%. For the same industry, the average monthly price growth was -5.74%, and the average quarterly price growth was +63.93%.

Reported Earning Dates

WXXWY is expected to report earnings on Dec 03, 2025.

Industries' Descriptions

@Biotechnology (-2.19% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IVBXF($19.7B) has a higher market cap than WXXWY($16.9B). IVBXF has higher P/E ratio than WXXWY: IVBXF (126.03) vs WXXWY (29.27). IVBXF YTD gains are higher at: 164.000 vs. WXXWY (82.270).
IVBXFWXXWYIVBXF / WXXWY
Capitalization19.7B16.9B117%
EBITDAN/AN/A-
Gain YTD164.00082.270199%
P/E Ratio126.0329.27431%
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
IVBXF vs WXXWY: Fundamental Ratings
IVBXF
WXXWY
OUTLOOK RATING
1..100
2956
VALUATION
overvalued / fair valued / undervalued
1..100
91
Overvalued
75
Overvalued
PROFIT vs RISK RATING
1..100
76100
SMR RATING
1..100
9561
PRICE GROWTH RATING
1..100
3843
P/E GROWTH RATING
1..100
5918
SEASONALITY SCORE
1..100
n/a90

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

WXXWY's Valuation (75) in the null industry is in the same range as IVBXF (91). This means that WXXWY’s stock grew similarly to IVBXF’s over the last 12 months.

IVBXF's Profit vs Risk Rating (76) in the null industry is in the same range as WXXWY (100). This means that IVBXF’s stock grew similarly to WXXWY’s over the last 12 months.

WXXWY's SMR Rating (61) in the null industry is somewhat better than the same rating for IVBXF (95). This means that WXXWY’s stock grew somewhat faster than IVBXF’s over the last 12 months.

IVBXF's Price Growth Rating (38) in the null industry is in the same range as WXXWY (43). This means that IVBXF’s stock grew similarly to WXXWY’s over the last 12 months.

WXXWY's P/E Growth Rating (18) in the null industry is somewhat better than the same rating for IVBXF (59). This means that WXXWY’s stock grew somewhat faster than IVBXF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IVBXFWXXWY
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
86%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
56%
Bullish Trend 2 days ago
77%
Momentum
ODDS (%)
Bullish Trend 2 days ago
65%
Bearish Trend 2 days ago
75%
MACD
ODDS (%)
Bullish Trend 2 days ago
59%
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
61%
Bearish Trend 2 days ago
77%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
61%
Bearish Trend 2 days ago
79%
Advances
ODDS (%)
Bullish Trend 23 days ago
70%
Bullish Trend 24 days ago
77%
Declines
ODDS (%)
Bearish Trend 21 days ago
52%
Bearish Trend 3 days ago
78%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
69%
Bullish Trend 2 days ago
80%
Aroon
ODDS (%)
Bearish Trend 2 days ago
55%
Bearish Trend 2 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
IVBXF
Daily Signal:
Gain/Loss:
WXXWY
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
JULZ46.120.15
+0.32%
Trueshares Structured Outcome July ETF
QBUF28.840.04
+0.15%
Innovator Nasdaq-100 10 Buffr ETF - Qt
SMDV64.13-0.16
-0.25%
ProShares Russell 2000 Dividend Growers
VDC208.19-1.24
-0.59%
Vanguard Consumer Staples ETF
OCCI4.39-0.16
-3.45%
OFS Credit Company

IVBXF and

Correlation & Price change

A.I.dvisor tells us that IVBXF and WXXWY have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IVBXF and WXXWY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IVBXF
1D Price
Change %
IVBXF100%
N/A
WXXWY - IVBXF
22%
Poorly correlated
-2.06%
ONC - IVBXF
22%
Poorly correlated
-2.87%
MDWD - IVBXF
20%
Poorly correlated
-2.46%
IVEVF - IVBXF
15%
Poorly correlated
N/A
INTI - IVBXF
11%
Poorly correlated
+11.55%
More

WXXWY and

Correlation & Price change

A.I.dvisor indicates that over the last year, WXXWY has been loosely correlated with WXIBF. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if WXXWY jumps, then WXIBF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To WXXWY
1D Price
Change %
WXXWY100%
-2.06%
WXIBF - WXXWY
46%
Loosely correlated
-7.56%
ONC - WXXWY
36%
Loosely correlated
-2.87%
SNBIF - WXXWY
28%
Poorly correlated
N/A
NAMS - WXXWY
23%
Poorly correlated
-0.75%
ZLAB - WXXWY
23%
Poorly correlated
+0.10%
More